Anne Kasus-Jacobi Selected Research

human AZU1 protein

1/2020	Antimicrobial Peptides Derived from the Immune Defense Protein CAP37 Inhibit TLR4 Activation by S100A9.
8/2018	The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease.
1/2017	Effect of Cationic Antimicrobial Protein CAP37 on Cytokine Profile during Corneal Wound Healing.
1/2016	The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis.
10/2015	The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease.
2/2015	A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties.
7/2014	Corneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCδ).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Kasus-Jacobi Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 08/2018 - 01/2014
4	Wounds and Injuries (Trauma) 06/2017 - 07/2014
4	Cataract (Cataracts) 10/2012 - 01/2009
3	Neuroinflammatory Diseases 08/2018 - 10/2015
3	Eye Diseases (Eye Disease) 01/2014 - 01/2009
3	Vision Disorders (Hemeralopia) 11/2009 - 01/2009
2	Corneal Injuries 01/2020 - 01/2017
2	Inflammation (Inflammations) 06/2017 - 10/2012
2	Infections 06/2017 - 02/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2014
2	Diabetes Mellitus 01/2014 - 11/2009
2	Macular Degeneration (Age-Related Maculopathy) 09/2011 - 11/2009
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2009 - 01/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2009 - 01/2009
1	Eye Infections 06/2017
1	Eye Injuries (Eye Injury) 06/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Sarcopenia 01/2014
1	Cognitive Dysfunction 01/2014
1	Proliferative Vitreoretinopathy 10/2012
1	Stargardt Disease 09/2011
1	Retinal Diseases 09/2011
1	Retinal Dystrophies 01/2010
1	Leber Congenital Amaurosis 01/2010
1	Blindness (Hysterical Blindness) 11/2009
1	Retinal Degeneration 03/2009
1	Acidosis 01/2009
1	Retinal Artery Occlusion 01/2009
1	Neovascular Glaucoma 01/2009
1	Hyperglycemia 01/2009
1	Retinal Vein Occlusion 01/2009

Drug/Important Bio-Agent (IBA)

7	human AZU1 proteinIBA 01/2020 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 08/2018 - 01/2009
5	Pharmaceutical PreparationsIBA 06/2017 - 01/2009
5	CarnosineIBA 01/2014 - 01/2009
4	N-acetylcarnosineIBA 10/2012 - 01/2009
3	Ophthalmic Solutions (Eye Drops)IBA 11/2009 - 01/2009
3	HydrazinesIBA 11/2009 - 01/2009
2	Antimicrobial PeptidesIBA 01/2020 - 06/2017
2	carcinineIBA 01/2014 - 10/2012
2	AntioxidantsIBA 11/2009 - 01/2009
2	Advanced Glycation End ProductsIBA 01/2009 - 01/2009
1	Cathepsin GIBA 08/2018
1	Leukocyte Elastase (Neutrophil Elastase)IBA 08/2018
1	Coloring Agents (Dyes)IBA 06/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2017
1	HydrogelsIBA 06/2017
1	SteroidsIBA 06/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2017
1	CytokinesIBA 01/2017
1	Biological ProductsIBA 01/2016
1	Peptides (Polypeptides)IBA 02/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014
1	Retinaldehyde (Retinal)IBA 09/2011
1	retinol dehydrogenaseIBA 01/2010
1	Membrane LipidsIBA 11/2009
1	AldehydesIBA 11/2009
1	LubricantsIBA 11/2009
1	CurcuminIBA 03/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2009
1	LigandsIBA 01/2009
1	aminoacyl-histidine dipeptidaseIBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	ProdrugsIBA 01/2009
1	Lubricant Eye Drops (Artificial Tears)IBA 01/2009
1	DipeptidesIBA 01/2009

Therapy/Procedure

5	Therapeutics 06/2017 - 01/2009
2	Topical Administration 02/2015 - 01/2009
1	Intravitreal Injections 10/2012
1	Complementary Therapies (Alternative Medicine) 11/2009
1	Contact Lenses 01/2009